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Evaluation of health-related quality of life (HRQoL) among people with diabetes has been growing in Iran over the
last decade. The main aim of the current study was to systematically review the characteristics of these studies and
examine quality of their findings. Persian (SID, Magiran) and English (Pubmed, Medline, Web of Science, CINAHL,
Scopus, PsycINFO and ERIC) databases were systematically searched using the search terms: “diabetes” AND “quality
of life” AND “Iran”. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines
were followed. A total of 46 studies passed the inclusion criteria and were included in the review. The included
studies were conducted in 20 out of 30 provinces of the country. Most studies investigated HRQoL among people
with type 2 diabetes. The Short Form Health Survey (SF-36) and WHO quality of life instruments (WHOQOL) were
the main instruments used in these studies. Studies showed that people with diabetes had lower HRQoL than
people without diabetes. Better socioeconomic status and better control of cardiovascular risk factors were
associated with better HRQoL among the patients with diabetes. In general, the predictors of HRQoL among Iranian
patients were similar to their international counterparts implying that diabetes patients share many common
features. The reviewed studies suffer from major methodological and reporting flaws which limit validity and
generalizability of their findings.
Keywords: HRQoL, Diabetes, Systematic review, IranIntroduction
Due to insufficiency of traditional end points (which are
mainly focused on the biologic and physiologic out-
comes) in capturing the effects of interventions on pa-
tients’ health-related quality of life (HRQoL), a growing
interest has emerged during the past decades for asses-
sing determinant factors of patients’ HRQoL, especially
in chronic diseases [1]. Diabetes mellitus is one of these
chronic diseases that involve people of all ages and races.
It is considered as one of the most common chronic dis-
eases in approximately all countries, and its prevalence
continues to increase mainly due to the changes in life-
styles resulting in physical inactivity, and increased obes-
ity [2]. It was estimated that diabetes affected 285
million adults (20–79 years) worldwide in 2010, and this
figure will increase to 439 million adults by 2030 [2].* Correspondence: aliasghar.ahmad_kiadaliri@med.lu.se
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reproduction in any medium, provided the orDiabetes is associated with higher risk of some macro
and microvascular complications. As result, these com-
plications cause mortality rate among diabetic patients
to be about twice as much as that of non-diabetic indi-
viduals of a similar age [3,4]. Moreover, patients with
these complications have lower HRQoL than diabetes
patients without the complications [5,6].
In Iran, prevalence of diabetes increased from 7.7% in
2005 to 8.7% in 2007 [7,8]. In addition, it was estimated
that annual direct medical cost of diabetes is roughly US
$ 113 million and direct medical cost in patients with
diabetes is about 3 times higher than general population
in the country [9]. High prevalence of diabetes and its
related complications have attracted the research and
policy concern in the country over last few years. In re-
sponse to this policy concern, a considerable body of lit-
erature has been emerged to evaluate HRQoL and its
determinants in diabetic patients. These studies aimed
to improve HRQoL in people with diabetes by providing
evidence for informed decision-making. However, differ-
ences in the research questions, tools and populationl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an obvious answer applicable for policy making pur-
poses. In response to this, conducting a systematic re-
view of individual studies to make the available
evidences more accessible for policy-making is common
in medical researches.
In this course, the current systematic review was con-
ducted to describe the latest available information about
HRQoL in people with diabetes in Iran. Specifically, this
review aimed to investigate how HRQoL was measured
in Iranian diabetic population, what were the main
methodological flaws of these studies, and which factors
were mainly associated with HRQoL in people with
diabetes.Method and materials
Literature search
A systematic literature search was independently con-
ducted in March 2012 to review the studies which evalu-
ated HRQoL among people with diabetes in Iran. The
results of this literature search were independently veri-
fied and updated in June 2012. Studies published up to
May 2012 were included in the review. National (SID,
Magiran) and international databases (Pubmed, Medline,
Web of Science, CINAHL, Scopus, PsycINFO and ERIC)
were searched through following search terms: [“dia-
betes” AND “quality of life” AND “Iran”]. Moreover, we
searched Google for extra Persian publications. We
followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [10].Selection of studies
Five exclusion criteria were applied: (1) the study did not
investigate HRQoL in people with diabetes, (2) the study
did not provide any data about HRQoL among study
population (e.g., the study was related to instrument de-
velopment in patients with diabetes); (3) the study was a
review article; (4) the study was not a journal article
(e.g., conference abstracts and dissertations); (5) the
study was not applied to the Iranian population.
The initial search resulted in 214 documents. After ex-
cluding duplicates and non-relevant studies, 59 articles
were selected for full text examination. The reference
lists of these 59 documents were manually searched. In
total, 46 studies were included for the review (Figure 1).
In cases where multiple publications were produced
from a single study, the paper with most comprehensive
data was included.
Data extracted from the selected studies are included,
among others: year of publication, the location (or prov-
ince) and the year the studies were conducted, study de-
sign, sample size, type of diabetes, age range of the
sample, duration of diabetes, HRQoL measurement toolused, main predictors of HRQoL, and statistical methods
used for analysis.
Results
General characteristics
The characteristics of 46 eligible studies [11-56] for this
review are shown in Table 1. First study was published
in year 2003 and since then there were few publications
per year on the topic, with a peak in the publications in
2011 (Figure 2). HRQoL in people with diabetes was in-
vestigated in 20 out of 30 provinces of the country. 17
out of 46 studies were conducted in two provinces
(Tehran & Hormozgan). Sample sizes across the studies
ranged from 27 to 387 participants. Majority of the stud-
ies (76%) were published in a national Persian language
journal. Cross-sectional design was the dominant design
in the studies (N=32). In terms of type of diabetes, five
studies included only people with type 1 diabetes and 23
studies covered only type 2 diabetic patients. In the
remaining studies, there was a combination of type1,
type2, and non-diabetes people in the sample. The age
of participants ranged from 10 to 75 years old. In most
studies, women constituted the majority of the study
participants.
HRQoL instruments
Regarding the instrument used to measure HRQoL, 17
different instruments were used in the studies. 25 studies
used a generic measure, 13 studies used a disease-
specific instrument and 7 studies applied both generic
and disease-specific instruments among the study popu-
lation. 14 studies used the Short Form Health Survey
(SF-36) and 10 studies employed WHO quality of life in-
struments (WHOQOL) to evaluate HRQoL in patients
with diabetes. In 10 studies an Iranian questionnaire, de-
veloped by authors or research teams of those studies or
adapted from other Iranian researchers, were applied.
HRQoL in diabetes patients vs. non-diabetes
Six studies, which examined the effect of diabetes on
HRQoL, compared HRQoL in people with and without
diabetes and reported negative effects of both type 1 and
type 2 diabetes on HRQoL.
The effects of interventions
A total of 12 studies examined the effects of an interven-
tion on HRQoL in people with diabetes. All studies, but
one, evaluated the effects of educational interventions
on HRQoL in people with diabetes and demonstrated
improvements in HRQoL caused by these interventions.
Diabetes-related complications
Six studies mainly examined the effects of diabetes-related
complications on HRQoL in patients with diabetes and
Figure 1 Flow diagram of the literature search.
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In addition, among remaining studies, 9 studies included
these complications as a predictor of HRQoL and found
that these complications were associated with lower
HRQoL.
Other predictors of HRQoL
Association between HRQoL and some demographic,
socioeconomic and clinical predictors were examined in
the most studies. Except one study, all the other studies
found a negative association between age and HRQoL.
Moreover, in all studies except one, females had lower
HRQoL than males. Better socioeconomic status (includ-
ing income, education, employment) of individuals and/
or their family was associated with better HRQoL. Better
HRQoL was reported for married compared to non-
married (single, widow) people. People with higher
HbA1c generally had lower HRQoL. There were nega-
tive associations between blood pressure, blood lipid andHRQoL. Lower level of HRQoL was found among
people with higher BMI. While most studies found a
negative association between HRQoL and duration of
diabetes, two studies reported a positive association.
Smokers had worse HRQoL than their non-smoker
counterparts. Two studies examined rural/urban dispar-
ities in HRQoL, but their results were not consistent,
showing opposite results. In general, patients who were
under diet treatment had better HRQoL than patients
on drug or/and insulin therapies.
Discussion
To our knowledge, for the first time, the current study has
reviewed the results of 46 identified studies examining
HRQoL among the Iranian patients with diabetes. The
findings of this review showed that generally people with
diabetes have worse HRQoL than their healthy counter-
parts. In addition, the findings indicated that diabetes-
related complications have a significant negative impact on
Table 1 Characteristics of the studies included in the review
First author Data
year
Language Province Main interest
variable
Study
design
Sample characteristics HRQoL assessment Statistical
analysis
Type of
diabetes (%)
Sample
size
Age
range
Females (%) Diabetes
duration
(mean/median)
Instrument Specific
or
generic?
Adjusted
(A) or
unadjusted
(U)?
Aghamolaei T, 2003
[11]
- English Hormozgan Predictors of
HRQoL
Cross
sectional
Type 2 (100) 80 32-72 58.8 5.8 WHOQOL-BREF Generic U
Aghamolaei T, 2005
[12]
- Persian Hormozgan Health
education
Quasi-
experimental
Type 2 (100) 71 - 59.2 6.0 WHOQOL-BREF Generic U
Ahari SS, 2008 [13] 2004 Persian Ardebil Type 2
diabetes
Cross-
sectional
Type 2 (100) 110 - 66.4 8 SF-36 Generic U
Ahmadi A, 2011 [14] 2008 Persian Chaharmahal
Bakhtiari
Predictors of
HRQoL
Cross-
sectional
Type 2 (100) 254 30-65 59 7.4 Developed by
research team
Specific A
Alavi A, 2010 [15] 2008 Persian Chaharmahal
Bakhtiari
Type 1
diabetes
Historical
cohort
Type 1 (14.5),
non-diabetes
(85.5)
152 8-18 52.4 in
diabetes
group
NA PedSQL Generic U
Alavi NM, 2004 [16] 2003 Persian Tehran Predictors of
HRQoL
Cross-
sectional
Type 1 (13),
Type 2 (87)
104 >18 65 9.7 Developed by
research team,
Well Being Index
Specific,
generic
U
Bagheri H, 2005 [17] NA Persian Semnan Micro-&
macrovascular
complications
Cross-
sectional
Type 2 (100) 150 35-65 NA NA Audit of Diabetes
Dependent
Quality of Life
Specific U
Baghianimoghadam
MH, 2007 [18]
NA Persian Yazd Health
education
Quasi-
experimental
Type 2 (100) 120 25-75 59 9.87 SF-20 Generic U
Bazzazian S, 2010
[19]
NA Persian Tehran Coping
strategies
Cross-
sectional
Type 1 (100) 300 18-30 57.3 NA D-39 Specific A
Borzou SR, 2010 [20] NA Persian Hamedan HRQoL level Cross-
sectional
Type 2 (100) 165 NA 67.3 NA SF-36 Generic U
Delvarianzadeh M,
2006 [21]
NA Persian Semnan Diet
consultation
RCT Type 2 (100) 144 35-65 67.8 NA SF-36 Generic U
Farahani TS, 2010
[22]
2007 Persian Tehran Age and sex Cross-
sectional
Type 1 (100) 70 11-18 52.1 2.23 Diabetes Quality
of Life for Youth
Specific U
Ghanbari A, 2004
[23]
2000 Persian East
Azerbaijan
Predictors of
HRQoL
Quasi-
experimental
Type 2 (100) 137 NA 86.1 NA NA Generic,
specific
A
Ghanbari A, 2004
[24]
NA Persian Gilan Type 2
diabetes
Cross-
sectional
Type 2 (51.1),
non-diabetes
(48.9)
176 >40 78.8%
(diabetic
group), 55.8%
(non-diabetic
group)
NA SF-36, SWED-
QUAL
Generic A
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Table 1 Characteristics of the studies included in the review (Continued)
Ghanbari A, 2005
[25]
2000 English East
Azerbaijan
Predictors of
HRQoL
Cross-
sectional
Type 2 (100) 117 >35 85.5 NA SWED-QUAL,
diabetes-specific
quality-of-life
scale
Generic,
specific
A
Ghavami H, 2005
[26]
2003-
2004
Persian West
Azerbaijan
Continious care Quasi-
experimental
Type 2 (100) 74 40-65 NA NA Developed by
research team in
Iran (Alavi NM)
Specific U
Haririan H, 2009 [27] 2007 Persian East
Azerbaijan
Aspects of
HRQoL
Cross-
sectional
Type 2 (100) 150 20-
>60
61.33 NA SF36+Swed-
QUAL, a
diabetes-specific
questionnaire
Generic,
specific
A
Hashemi Hefzabad
F, 2011 [28]
NA English Isfahan Diabetes
impact on
HRQoL
Cross-
sectional
Diabetes
(50), non-
diabetes (50)
204 20-60 52% in both
groups.
NA Hanestad &
Albrektsen’s
Attitude to
Quality of Life
Generic U
Heidari M, 2007 [29] 2004-
2005
Persian Zanjan Empowerment
model
Quasi-
experimental
Type 1 (100) 47 11-20 - - - - U
Jafari P, 2011 [30] NA English Fars Impact of type
1 diabetes on
HRQoL
Cross-
sectional
Type 1 (32),
healthy (68)
294 8-18 56.4% in
diabetes and
53% in
healthy
group.
NA PedsQL™ 4.0
Generic Core
Scales, PedsQL™
3.0 Diabetes
Module
Generic,
specific
A
Jahanlou AS, 2007
[31]
2006 Persian Hormozgan Smoking Cross-
sectional
Type 2 (100) 125 NA NA NA WHOQOL-BREF
26
Generic U
Jahanlou AS, 2008
[32]
2007 Persian Hormozgan Glycemic
control
Cross-
sectional
Type 2 (100) 110 27-72 66.9 6.33 WHOQOL-BREF
26
Generic U
Jahanlou AS, 2011
[33]
2007 English Hormozgan Education Cross-
sectional
Type 2 (100) 256 27-72 67.5 6.33 WHOQOL-BREF
26
Generic U
Jahanlou AS, 2011
[34]
2006 English Hormozgan HbA1c Cross-
sectional
Type 1 (11.8),
Type 2 (88.2)
76 NA 60.5 NA WHOQOL-BREF
26, Iranian
Diabetics’ Quality
of Life
Generic,
specific
U
Jahanlou AS, 2011
[35]
2007 English Hormozgan - Cross-
sectional
Type 2 (100) 387 27-72 51.9 5.83 WHOQOL-BREF
26, Iranian
Diabetics’ Quality
of Life
Generic,
specific
U
Kakhaki AD, 2006
[36]
2004 Persian Tehran Predictors of
HRQoL
Cross-
sectional
Type 1 (15.3),
Type 2 (84.7)
131 18-65 60.3 6.10 SF-36 Generic U
Kasbakhi MS, 2008
[37]
2008 Persian Mazandaran Type 2
diabetes
Case–control Type 2 (48.3),
non-diabetes
(51.7)
145 NA 90% in
diabetic
group and
81.3% in
non-diabetic
group.
NA SF-36, SWED-
QUAL
Generic U
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Table 1 Characteristics of the studies included in the review (Continued)
Kermansaravi F,
2012 [38]
2011 Persian Sistan &
Baluchestan
Predictors of
HRQoL
Cross
sectional
Type 1 (100) 100 10-18 47 3.5 Diabetes quality
of life youth
Specific U
Khaledi S, 2011 [39] 2009 Persian Kordestan Predictors of
HRQoL
Cross-
sectional
Type 2 (100) 198 >18 83.8 NA SF-36 Generic U
Khamseh MA, 2011
[40]
2009-
2010
Persian NA Aspects of
HRQoL
Cross-
sectional
Type1 (100) 150 12-30 49.3 8.97 Developed by
research team
Specific A
Nejatisafa, 2008 [41] 2005 Persian Tehran HbA1c Cross
sectional
Type 1 (4),
Type 2 (96)
100 18-65 68.0 9 WHOQOL-BREF Generic A
Peymani M, 2006
[42]
2005 Persian Tehran Neuropathy Cross
sectional
Type 1, Type
2
304 >18 76.1 NA Developed by
research team
Specific A
Peymani M, 2007
[43]
2004-
2005
Persian Tehran Cardiovascular
disease
Cross
sectional
Type 1, Type
2
302 >18 76.1 NA Developed by
research team
Specific A
Peymani M, 2008
[44]
2005 Persian Tehran Retinopathy Cross
sectional
Type 1, Type
2
178 >18 75.8 NA Developed by
research team
Specific A
Rakhshandehru,
2006 [45]
2001-
2002
Persian Tehran Health
education
Quasi-
experimental
Type 2 (100) 44 40-65 45.5 NA Specific U
Rasouli D, 2011 [46] 2008 Persian Tehran The predictors
of HRQoL
Cross
sectional
Patients with
diabetic foot
ulcer (100)
120 >45-
65<
40.0 NA Diabetic foot
scale
questionnaire
Specific U
Safavi M, 2011 [47] 2009-
2010
English Ardebil Health
education
Randomised
controlled
trial
Type 2 (100) 123 30-70 50.8%
(experiment),
51.6%
(control)
NA Farrell and Grant
quality of life
questionnaire
Generic U
Sanjari M, 2011 [48] - English Kerman Foot ulcer Case–control Type 1 (11.4),
Type 2 (88.6)
132 - 37.9 10.9 SF-36 Generic A
Sayadi N, 2011 [49] 2007 Persian Khuzestan Open heart
surgery
Case–control Type 2 (38.8),
non-diabetes
(61.2)
80 35-75 65%
(diabetic),
33% (non-
diabetic)
4.3 SF-36 Generic U
Shahrjerdi S, 2009
[50]
2008 Persian Markazi Physical
excercise
Quasi-
experimental
Type 2 (100) 27 >35 100 5.3 SF36, General
Health
Questionnaire
Generic U
Shareh H, 2012 [51] - Persian Fars Perceived
social support
Cross
sectional
Type 2 (100) 50 NA NA NA Multidimensional
Scale of
Perceived Social
Support,
WHOQOL-BREF
Generic A
Taghdisi MH, 2012
[52]
2009 English Golestan Health
education
Quasi-
experimental
Type 2 (100) 78 NA 79.5 NA WHOQOL Generic U
Timareh M, 2012
[53]
- Persian Kermanshah Predictors of
HRQoL
Cross
sectional
Type 1 (4),
Type 2 (96)
350 >18 58.3 NA SF-36 Generic U
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Table 1 Characteristics of the studies included in the review (Continued)
Vares Z, 2010 [54] 2006 Persian Isfahan Predictors of
HRQoL
Cross
sectional
Type 1 (18.4),
Type 2 (81.6)
310 >18 74 10.9 Iranian Diabetes
Quality of Life
questionnaire
Specific A
Vazirinejad R, 2010
[55]
2007 Persian Kerman Diabetes Historical
cohort
Diabetes
(45.1), non-
diabetes
(54.9)
224 <30-
>60
76.3 8.0 SF-36 Generic U
Yekta Z, 2011 [56] 2009-
2010
English West
Azerbaijan
Foot ulcer Cross-
sectional
Type 2 (100) 250 - 61.6 7.7 SF-36 Generic A
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Figure 2 Number of studies by year of publication.
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sociations between covariates and HRQoL in the reviewed
Iranian studies were in line with their international
counterparts.
The reviewed studies suffer from major methodo-
logical and reporting flaws which affected quality of their
findings and limit their validity and generalizability. The
reviewed studies mainly applied a nonrandom sampling
method leading to possible selection bias. Moreover, cal-
culation of sample size was unclear in the majority of
the studies. Furthermore, while most studies were obser-
vational, univariate analysis was the main statistical ap-
proach used for data analysis and minimum effort was
done to control for any imbalance in the covariates lead-
ing to potential confounder and selection biases. Among
studies which employed multivariate analysis, some of
the main confounding factors (such as diabetes-related
complications and duration of diabetes) were not con-
trolled for, raising possibility of confounder bias. In
addition, these studies didn’t explain their limitations ad-
equately and did not comment on the potential biases in
their reported results. Although, generic instruments
were used by the most studies, limitations of these in-
struments in capturing HRQoL in patients with diabetes
were not fairly explained. Moreover, several studies
failed to validate the instruments before putting to use
in a new population and only referred to application of
the instruments in a diabetic population in other coun-
tries or a general population in Iran. It seems that simi-
lar to few other settings [57], Iranian researchers have
used the instruments applied in other studies without
worrying about their content.
The results of the current review should be interpreted
in light of few limitations. Firstly, although Persian data-
bases used in this review consisted majority of the arti-
cles published nationally, there is a possibility that somestudies may not be included in these databases. Sec-
ondly, as a wide range of instruments were used in the
reviewed studies and the transparency of reported re-
sults was limited, it was not possible to apply statistical
methods such as meta-analysis to test association be-
tween the covariates and HRQoL. Increasing the number
of studies applying the same instrument and improving
transparency of reporting results may make it possible
to conduct a meta-analysis in future.
The previous systematic reviews mainly have focused
on evaluating and comparing measurement properties of
instruments used in examining HRQoL among diabetes
patients [57-61]. In a review of HRQoL studies among
people with diabetes in Nordic countries, Wandell [62]
found that diabetes had a negative effect on HRQoL and
being at older age, having diabetes-related complica-
tions, having lower socioeconomic status, being female
and having weaker control of clinical risk factors were
associated with lower HRQoL. These findings are com-
parable to the findings of the current review.
In conclusion, growing interests in evaluating HRQoL
among people with diabetes were observed in Iran over
the last decade. The findings of this review showed that
people with diabetes had a lower HRQoL than healthy
people. The findings also indicated that better socioeco-
nomic status and better control of cardiovascular risk
factors were associated with better HRQoL among the
patients with diabetes. The reviewed studies suffer from
major methodological and reporting flaws which limit
the validity and generalizability of their findings.
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